CREBBP/EP300 mutation is associated with poor outcome in HNSCC and targetable with synthetic cytotoxicity
Manish Kumar,David Molkentine,Jessica Molkentine,Kathleen Bridges,Tongxin Xie,Liangpeng Yang,Meng Gao,Mitchell J. Frederick,Sahil Seth,Mohamed Abdelhakiem,Faye Johnson,Jing Wang,Li Shen,Timothy Heffernan,Aakash Sheth,Robert Ferris,Jeffrey N. Myers,Curtis R. Pickering,Heath D. Skinner biorxiv(2020)
AI 理解论文
溯源树
样例